Zepbound® and menstrual changes

Where cycles appear in the Zepbound® documents

No menstrual side effect is listed in any of the three sets of product information ^[1][3][4]. Cycles appear only in animal data: in fertility studies, a larger share of female rats on tirzepatide spent longer in diestrus, the quiet phase of the rodent cycle, and they formed fewer corpora lutea, which develop where an egg has been released, which meant fewer implantation sites and embryos at every dose tested ^[1][3]. The US label and the Canadian monograph both describe these effects as secondary to reduced food intake and body weight ^[1][3], and the EU says animal studies showed no direct harm to fertility, while the effect on human fertility is unknown ^[4].

Who was in the Zepbound® trials

This is a Zepbound®-specific point that changes how cycle changes should be read. Of the people treated with Zepbound® in SURMOUNT-1 and SURMOUNT-2, 37% were men, so roughly six in ten were women, and the average age was 47 ^[1]. That puts many participants in or near perimenopause, when cycles naturally become less predictable ^[11].

A post hoc analysis of SURMOUNT-1, -3 and -4 sorted women into premenopause, perimenopause and postmenopause stages. In SURMOUNT-1, weight fell by about 26%, 23% and 23% on tirzepatide against 2% to 3% on placebo, with similar results in the other two trials ^[5]. The analysis looked at weight and waist size, not periods, so it says nothing directly about cycles, but it shows the trials included women at every stage.

What human studies report

There are no trial data on periods in Zepbound® users, and the evidence from report databases is contradictory. A 2026 analysis of FDA reports in women aged 12 to 55 found tirzepatide signals for bleeding between periods and menstrual clots, with semaglutide showing a broader set of signals ^[6]. Another 2026 analysis of the same database found tirzepatide had lower reporting odds than expected for painful periods, absent periods and heavy bleeding ^[7]. Spontaneous reports cannot give rates or show cause, and different methods can produce different answers.

For polycystic ovary syndrome, a 16-week randomised trial in 60 Chinese women with overweight or obesity compared low-dose tirzepatide plus metformin with metformin alone. The combination produced more weight loss, and more women regained regular cycles and became pregnant ^[8]. A UK study of 54,114 women prescribed tirzepatide for weight management found similar weight loss in those who reported PCOS and those who did not; it did not measure cycles ^[9]. Zepbound® is not approved to treat PCOS.

Why a cycle might shift on Zepbound®

Three layers, from best to least supported.

• Supported in animals. The label links the rat cycle changes to reduced food intake and body weight rather than a direct hormonal effect ^[1]. Whether the same happens in people has not been studied.
• Plausible in people. MedlinePlus lists sudden large weight loss, strict diets, low body fat, intense exercise and severe stress among reasons periods can stop, and excessive weight gain or loss among causes of irregular bleeding ^[10][11]. Losing a large amount of weight on Zepbound® could, in principle, have similar effects.
• Background change. MedlinePlus counts obesity itself among risk factors for absent periods and notes that such cases may respond to weight change ^[10], so some people may find cycles becoming more regular rather than less.

Other causes of period changes

MedlinePlus lists pregnancy as the most common reason periods stop in someone who had regular cycles, with breastfeeding and menopause as other natural causes ^[10]. Polycystic ovary syndrome, reduced or failing ovarian function, an overactive thyroid, pituitary tumours, adrenal disorders, some psychiatric and cancer medicines, and scarring of the uterus after procedures or infection are among the medical causes ^[10]. Coming off hormonal birth control can delay the return of periods for months ^[10].

For irregular or heavier bleeding, MedlinePlus points to hormone imbalance, which is more common in teenagers and before menopause, as well as fibroids or polyps, thickening of the uterine lining, bleeding disorders, infection, hormonal contraceptives and IUDs, and, less often, cancers ^[11]. It notes that women who are overweight may be more likely to have abnormal bleeding ^[11].

When your cycle shifts: practical steps

If a period is late or missed, take a pregnancy test. The US label says to stop Zepbound® once pregnancy is recognised and points to a pregnancy registry, and Canada considers Zepbound® contraindicated in pregnancy ^[1][3]. If you are planning a pregnancy, Canada and the EU ask for tirzepatide to be stopped at least one month beforehand ^[3][4]. The details on how Zepbound® affects birth control pills are on the separate oral contraceptives page.

MedlinePlus suggests keeping track of your period each month so changes are easier to spot, and talking to a provider about major changes, very heavy bleeding or severe pain ^[12]. It advises seeing a provider if you have missed more than one period ^[10]. Tiredness with heavy periods can signal anaemia ^[11].

Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.

When to get help